查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1428026

2024 年脊髓刺激全球市场报告

Spinal Cord Stimulation Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

脊髓刺激市场规模预计在未来几年将显着成长。预计到 2028 年将以 8.3% 的复合年增长率 (CAGR) 增长至 43.1 亿美元。预测期内的预期成长可归因于创新刺激疗法的开发、脊髓刺激适应症的扩大、微创手术需求的增加、研发投资的增加以及有利的报销政策。预测期内预计的主要趋势包括将人工智慧整合到脊髓刺激设备中、基于感觉异常的刺激的出现、注重扩大新兴经济体的市场份额以及可充电刺激器的增加。中心性等等。产品开发中的方法。

脊髓损伤盛行率的预期增加预计将推动未来脊髓刺激市场的成长。脊髓损伤包括脊髓或脊椎内神经的任何损伤，通常由外伤事件或家庭事故引起。脊髓损伤的治疗包括脊髓刺激，这是一种向脊髓输送低压电以减轻疼痛的过程。截至 2022 年 5 月，国家医学图书馆报告称，全世界每年有 25 万至 50 万人受到脊髓损伤的影响。仅在美国，每年就会报告约 17,000 例新的脊髓损伤，估计有 282,000 名美国人被认为是脊髓损伤的倖存者。因此，脊髓损伤的盛行率日益增加，成为脊髓刺激市场扩张的催化剂。

老年人口的增加预计将有助于脊髓刺激市场的成长。 65 岁及以上的老年人口经历着与老化过程相关的独特医疗和社会需求。老年人口的不断增长，以及与老龄化相关的疾病和慢性疼痛的流行，为脊髓刺激提供了巨大的市场机会。 2021年5月，社区生活部（ACL）的报告显示，65岁以上人口将从2009年的3,960万增加到2019年的5,410万，增加36%。预测称，到 2060 年，这一人口将达到 9,470 万人。据估计，到 2040 年，这一数字将超过 8,080 万。自 2000 年以来，这种人口变化增加了一倍多，预计到 2040 年将占总人口的 21.6%，高于 2019 年的 16%。因此，老年人口的扩大是驱动力。我们将推动脊髓刺激市场的成长。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球脊髓电刺激市场的驱动与限制因素
    • 市场驱动因素
    • 市场限制因素
  • 2018-2023年全球脊髓刺激市场规模表现与成长
  • 2023-2028、2033年全球脊髓刺激市场规模及成长预测

第六章市场区隔

  • 全球脊髓刺激市场，依产品细分、实际及预测，2018-2023、2023-2028、2033
  • 可充电的
  • 不可充电
  • 全球脊髓刺激市场，按应用细分、实际和预测，2018-2023、2023-2028、2033
  • 腰部手术失败症候群（FBSS）
  • 退化性疾病(DDD)
  • 复杂局部疼痛综合症 (CRPS)
  • 蜘蛛网膜炎
  • 其他的
  • 全球脊髓刺激市场，按最终用户细分，实际和预测，2018-2023、2023-2028、2033
  • 医院
  • 门诊手术中心
  • 专科诊所

第 7 章 区域与国家分析

  • 全球脊髓刺激市场，按地区、绩效和预测，2018-2023、2023-2028、2033
  • 全球脊髓刺激市场，依国家、表现及预测，2018-2023、2023-2028、2033

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争形势及公司概况

  • 脊髓电刺激市场竞争形势
  • 脊髓刺激市场公司简介
    • NeuroPace Inc.
    • Abbott Laboratories
    • Medtronic PLC
    • Stryker Corporation
    • Boston Scientific Corp.

第31章 其他大型创新公司

  • LivaNova PLC
  • Globus Medical Inc.
  • ZimVie Inc.
  • Avanos Medical Inc.
  • Inspire Medical Systems Inc.
  • Nevro Corp.
  • Axonics Modulation Technologies Inc.
  • SPR Therapeutics Inc.
  • BlueWind Medical
  • Bioness Inc.
  • Saluda Medical Pty. Ltd.
  • Soterix Medical Inc.
  • Synapse Biomedical Inc.
  • NeuroMetrix Inc.
  • NDI Medical LLC

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章 未来前景与潜力分析

第36章附录

简介目录
Product Code: r13870

Spinal cord stimulation is a relatively recent technique designed to aid in the management of chronic pain when the underlying damage or cause cannot be remedied. This approach involves delivering electrical pulses directly into the spinal cord to regulate and control pain.

The primary types of spinal cord stimulation products are rechargeable and non-rechargeable. Rechargeable devices are those capable of being replenished with electricity. Rechargeable spinal cord stimulation is applied to address persistent neuropathic pain that persists after unsuccessful back surgery. Its applications extend to various conditions, including failed back surgery syndrome (FBSS), degenerative disc disease (DDD), complex regional pain syndrome (CRPS), arachnoiditis, among others. These products find use in different medical settings, including hospitals, ambulatory surgery centers, and specialty clinics.

The spinal cord stimulation market research report is one of a series of new reports from The Business Research Company that provides spinal cord stimulation market statistics, including spinal cord stimulation industry global market size, regional shares, competitors with a spinal cord stimulation market share, detailed spinal cord stimulation market segments, market trends and opportunities, and any further data you may need to thrive in the spinal cord stimulation industry. This spinal cord stimulation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The spinal cord stimulation market size has grown strongly in recent years. It will grow from $2.85 billion in 2023 to $3.12 billion in 2024 at a compound annual growth rate (CAGR) of 9.4%. The growth observed during the historical period can be attributed to factors such as an aging population, the increasing prevalence of chronic pain, rising awareness about spinal cord stimulation, and a growing demand for non-invasive pain management techniques.

The spinal cord stimulation market size is expected to see strong growth in the next few years. It will grow to $4.31 billion in 2028 at a compound annual growth rate (CAGR) of 8.3%. The anticipated growth in the forecast period can be attributed to the development of innovative stimulation therapies, the expansion of indications for spinal cord stimulation, a rising demand for minimally invasive procedures, increased investment in research and development, and favorable reimbursement policies. Major trends expected in the forecast period include the integration of artificial intelligence in spinal cord stimulation devices, the emergence of non-paresthesia-based stimulation, a focus on expanding market presence in emerging economies, the adoption of rechargeable stimulators, and an emphasis on patient-centric approaches in product development.

The expected rise in the prevalence of spinal cord injuries is anticipated to drive the growth of the spinal cord stimulation market in the future. Spinal cord injuries encompass any damage to the spinal cord or nerves within the spinal canal, often resulting from traumatic incidents or domestic accidents. The treatment for spinal cord injuries involves spinal cord stimulation, a process that delivers low-voltage electricity to the spinal cord to alleviate pain. As of May 2022, the National Library of Medicine reported that spinal cord injuries affected between 250,000 and 500,000 individuals globally each year. In the United States alone, approximately 17,000 new spinal cord injuries are reported annually, with an estimated 282,000 Americans considered survivors of spinal cord injuries. Consequently, the growing prevalence of spinal cord injuries is serving as a catalyst for the expansion of the spinal cord stimulation market.

The increasing demographic of the elderly population is expected to contribute to the growth of the spinal cord stimulation market. The geriatric population, aged 65 and older, experiences distinctive healthcare and social needs associated with the aging process. The expanding geriatric population represents a significant market opportunity for spinal cord stimulation, as age-related ailments and chronic pain become more prevalent. In May 2021, a report by The Administration for Community Living (ACL) indicated a 36% increase in the population aged 65 and older from 39.6 million in 2009 to 54.1 million in 2019. Projections suggest that this demographic will reach 94.7 million by 2060, with estimates indicating a figure surpassing 80.8 million by 2040. This demographic shift, more than doubling from 2000, is expected to constitute 21.6% of the total population by 2040, compared to 16% in 2019. Hence, the expanding geriatric population is a driving force for the growth of the spinal cord stimulation market.

Technological innovations are a prominent trend gaining traction in the spinal cord stimulation market, with major companies focusing on advanced solutions to maintain their market positions. In December 2022, Abbott Laboratories, a US-based medical device company, introduced the Eterna spinal cord stimulation system, the smallest implantable, rechargeable spinal cord stimulator for chronic pain management currently available. Utilizing Abbott's low-dose BurstDR stimulation, the Eterna SCS has demonstrated a 23% greater relief of pain compared to conventional waveform technology methods, providing a technologically advanced solution for chronic pain treatment.

Major players in the spinal cord stimulation market are concentrating on developing innovative products, such as the Spinal Cord Stimulation System, representing a significant advancement in therapy for spinal cord stimulation. The system involves the implantation of electrodes along the spinal cord to alleviate chronic pain. In March 2023, Nevro, a US-based medical device company specializing in chronic pain treatment, launched the Revolutionary HFX iQ Spinal Cord Stimulation System. Distinguished by its use of artificial intelligence, the system offers personalized pain relief through real-time adjustments based on extensive clinical data. Featuring the HFX algorithm and comprehensive pain management, this system not only represents a significant advancement in spinal cord stimulation therapy but also contributes to the market by offering innovative, data-backed, and AI-powered solutions for individuals with chronic pain.

In November 2023, Nevro, a US-based medical device company for chronic pain, completed the acquisition of VYRSA Technologies for an upfront payment of $40 million and an additional $35 million in milestone payments. This acquisition is notable in the spinal cord stimulation market, diversifying Nevro's product offering, expanding its portfolio and market reach, and addressing unmet medical needs in chronic pain treatment. VYRSA Technologies is a US-based medical technology company with a focus on sacroiliac joint fusion.

Major companies operating in the spinal cord stimulation market report are NeuroPace Inc., Abbott Laboratories, Medtronic PLC, Stryker Corporation, Boston Scientific Corp., LivaNova PLC, Globus Medical Inc., ZimVie Inc., Avanos Medical Inc. , Inspire Medical Systems Inc., Nevro Corp., Axonics Modulation Technologies Inc., SPR Therapeutics Inc., BlueWind Medical, Bioness Inc., Saluda Medical Pty. Ltd., Soterix Medical Inc., Synapse Biomedical Inc., NeuroMetrix Inc., NDI Medical LLC, Neuros Medical Inc., Cirtec Medical Corp., Mainstay Medical International PLC, Gimer Medical, NeuroSigma Inc.

North America was the largest region in the spinal cord stimulation market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the spinal cord stimulation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the spinal cord stimulation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The spinal cord stimulation market consists of sales of neurostimulators, leads, extensions, and handheld controllers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Spinal Cord Stimulation Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on spinal cord stimulation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for spinal cord stimulation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The spinal cord stimulation market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Product: Rechargeable; Non-rechargeable
  • 2) By Application: Failed Back Surgery Syndrome (FBSS); Degenerative Disc Disease (DDD); Complex Regional Pain Syndrome (CRPS); Arachnoiditis; Other Disease Indications
  • 3) By End User: Hospitals; Ambulatory Surgery Centers; Specialty Clinics
  • Companies Mentioned: NeuroPace Inc.; Abbott Laboratories; Medtronic PLC; Stryker Corporation; Boston Scientific Corp.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Spinal Cord Stimulation Market Characteristics

3. Spinal Cord Stimulation Market Trends And Strategies

4. Spinal Cord Stimulation Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Spinal Cord Stimulation Market Size and Growth

  • 5.1. Global Spinal Cord Stimulation Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Spinal Cord Stimulation Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Spinal Cord Stimulation Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Spinal Cord Stimulation Market Segmentation

  • 6.1. Global Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Rechargeable
  • Non-rechargeable
  • 6.2. Global Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Failed Back Surgery Syndrome (FBSS)
  • Degenerative Disc Disease (DDD)
  • Complex Regional Pain Syndrome (CRPS)
  • Arachnoiditis
  • Other Disease Indications
  • 6.3. Global Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Ambulatory Surgery Centers
  • Specialty Clinics

7. Spinal Cord Stimulation Market Regional And Country Analysis

  • 7.1. Global Spinal Cord Stimulation Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Spinal Cord Stimulation Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Spinal Cord Stimulation Market

  • 8.1. Asia-Pacific Spinal Cord Stimulation Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Spinal Cord Stimulation Market

  • 9.1. China Spinal Cord Stimulation Market Overview
  • 9.2. China Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Spinal Cord Stimulation Market

  • 10.1. India Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Spinal Cord Stimulation Market

  • 11.1. Japan Spinal Cord Stimulation Market Overview
  • 11.2. Japan Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Spinal Cord Stimulation Market

  • 12.1. Australia Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Spinal Cord Stimulation Market

  • 13.1. Indonesia Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Spinal Cord Stimulation Market

  • 14.1. South Korea Spinal Cord Stimulation Market Overview
  • 14.2. South Korea Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Spinal Cord Stimulation Market

  • 15.1. Western Europe Spinal Cord Stimulation Market Overview
  • 15.2. Western Europe Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Spinal Cord Stimulation Market

  • 16.1. UK Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Spinal Cord Stimulation Market

  • 17.1. Germany Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Spinal Cord Stimulation Market

  • 18.1. France Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Spinal Cord Stimulation Market

  • 19.1. Italy Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Spinal Cord Stimulation Market

  • 20.1. Spain Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Spinal Cord Stimulation Market

  • 21.1. Eastern Europe Spinal Cord Stimulation Market Overview
  • 21.2. Eastern Europe Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Spinal Cord Stimulation Market

  • 22.1. Russia Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Spinal Cord Stimulation Market

  • 23.1. North America Spinal Cord Stimulation Market Overview
  • 23.2. North America Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Spinal Cord Stimulation Market

  • 24.1. USA Spinal Cord Stimulation Market Overview
  • 24.2. USA Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Spinal Cord Stimulation Market

  • 25.1. Canada Spinal Cord Stimulation Market Overview
  • 25.2. Canada Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Spinal Cord Stimulation Market

  • 26.1. South America Spinal Cord Stimulation Market Overview
  • 26.2. South America Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Spinal Cord Stimulation Market

  • 27.1. Brazil Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Spinal Cord Stimulation Market

  • 28.1. Middle East Spinal Cord Stimulation Market Overview
  • 28.2. Middle East Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Spinal Cord Stimulation Market

  • 29.1. Africa Spinal Cord Stimulation Market Overview
  • 29.2. Africa Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Spinal Cord Stimulation Market Competitive Landscape And Company Profiles

  • 30.1. Spinal Cord Stimulation Market Competitive Landscape
  • 30.2. Spinal Cord Stimulation Market Company Profiles
    • 30.2.1. NeuroPace Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Abbott Laboratories
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Medtronic PLC
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Stryker Corporation
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Boston Scientific Corp.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Spinal Cord Stimulation Market Other Major And Innovative Companies

  • 31.1. LivaNova PLC
  • 31.2. Globus Medical Inc.
  • 31.3. ZimVie Inc.
  • 31.4. Avanos Medical Inc.
  • 31.5. Inspire Medical Systems Inc.
  • 31.6. Nevro Corp.
  • 31.7. Axonics Modulation Technologies Inc.
  • 31.8. SPR Therapeutics Inc.
  • 31.9. BlueWind Medical
  • 31.10. Bioness Inc.
  • 31.11. Saluda Medical Pty. Ltd.
  • 31.12. Soterix Medical Inc.
  • 31.13. Synapse Biomedical Inc.
  • 31.14. NeuroMetrix Inc.
  • 31.15. NDI Medical LLC

32. Global Spinal Cord Stimulation Market Competitive Benchmarking

33. Global Spinal Cord Stimulation Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Spinal Cord Stimulation Market

35. Spinal Cord Stimulation Market Future Outlook and Potential Analysis

  • 35.1 Spinal Cord Stimulation Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Spinal Cord Stimulation Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Spinal Cord Stimulation Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer